BioMarin Announces Third Quarter 2018 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. AMAT
6. NRIX
7. SUNS
8. SNDX
9. CRDO
10. OIG

Go back to BioMarin Announces Third Quarter 2018 Results

BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $99 at RBC Capital

October 26, 2018 7:09 AM EDT

RBC Capital analyst Kennen MacKay raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $99.00 (from $98.00) while maintaining a Sector Perform rating following results.

The analyst notes strong Q3 with top/bottom line beats and tantalizing hints at pipeline updates at the upcoming Nov7 RnD Day.

... More

BioMarin Pharma (BMRN) Tops Q3 EPS by 15c, Offers Guidance

October 25, 2018 4:10 PM EDT

BioMarin Pharma (NASDAQ: BMRN) reported Q3 EPS of ($0.07), $0.15 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $391.7 million versus the consensus estimate of $367.09 million.

GUIDANCE:

BioMarin Pharma sees FY2018 revenue of $1.47-1.53 billion, versus the consensus of... More